SecBot SecBot
144 ·Filed Aug 21, 2026

TECX

Tectonic Therapeutic, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago SEC0001950047-26-008563
Actionable Insight • Neutral

This is a routine post-exercise diversification sale by a former director with no current management role. The small size (~0.05% of market cap) and non-executive status of the filer make this a non-event for traders. Monitor for any subsequent Form 4 filings from current executives or larger insider sales, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
TECX ▼ -27.34% at T+20d
NEUTRAL call -27.34% · α vs SPY -28.65% · entry $36.47 → $26.50
Next anchor: T+60d in 20d
Latest observation: T+44 -51.19% FF3 residual α
Entry = T+0 close
Aug 21, 2026
via day close
T+1d
+3.40%
call +3.40% · α +3.08%
$37.71
settled 2mo ago
T+5d
-17.91%
call -17.91% · α -18.37%
$29.94
settled 2mo ago
T+20d
-27.34%
call -27.34% · α -28.65%
$26.50
settled 5w ago
T+60d
Pending
in 20d

Price Chart

Loading chart...

Executive Summary

Former director Terrance McGuire filed a Form 144 notice to sell 10,200 shares of Tectonic Therapeutic (TECX) valued at approximately $383,671, acquired via stock option exercise. The sale is small relative to the $705M market cap and represents a routine post-exercise diversification move by a former board member, not a management signal. The filing is a single notice (not a batch of distinct filings) and carries limited directional significance.

Key Facts

  • Former director Terrance McGuire filed Form 144 to sell 10,200 shares of TECX common stock.
  • Estimated sale value: ~$383,671 based on filing date price.
  • Shares were acquired via stock option exercise on the same day (08/21/2026).
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.
  • McGuire is a former director, not a current executive officer.
  • Sale represents ~0.05% of TECX's $705M market cap.
  • Only one distinct Form 144 was filed (accession number -26-008563); the 'batch' label reflects duplicate documents, not multiple filings.

Financial Impact

Proposed sale of 10,200 shares valued at ~$383,671; immaterial relative to $705M market cap.

dilution

Risk Factors

  • Insider may not complete the sale (Form 144 is an intent notice).
  • If followed by larger insider sales from current executives, could signal broader insider sentiment shift.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (TECX) — Batch item 10001950047-26-008563
Document: 0001950047-26-008563-index.html0001950047-26-008563
Document: 0001950047-26-008563.txt0001950047-26-008563
144 Filing (TECX) — Batch item 40001950047-26-008563
Document: 0001950047-26-008563-index.html0001950047-26-008563
Document: 0001950047-26-008563.txt0001950047-26-008563
8 reports for TECX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TECX — sortable, filterable
TypeNow
Aug 21, 2026
9w ago
144
NEUTRAL ★ 3/10
$36.47awaiting T+60—$19.95 (−45.30%)
Jun 11, 2026
19w ago
Institutional Cluster
BULLISH ★ 4/10
$29.34 $30.75▲ +4.81%▲ +0.41%$19.95 (−32.00%)
May 7, 2026
24w ago
8-K
BEARISH ★ 5/10
$29.00 $29.17▼ −0.59%▲ +4.25%$19.95 (+31.21%)
May 7, 2026
24w ago
Press Release
NEUTRAL ★ 4/10
$29.00 $29.17▲ +0.59%▼ −4.25%$19.95 (−31.21%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 3/10
$28.75 $31.59▲ +9.88%▲ +5.10%$19.95 (−30.61%)
Apr 3, 2026
29w ago
3
NEUTRAL ★ 2/10
$29.98 $32.74▲ +9.21%▼ −4.26%$19.95 (−33.46%)
Mar 6, 2026
33w ago
Insider Cluster
NEUTRAL ★ 4/10
$35.87 $28.89▼ −19.46%▼ −32.24%$19.95 (−44.38%)
Feb 24, 2026
34w ago
8-K
NEUTRAL ★ 3/10
$23.11 $28.84▲ +24.79%▲ +17.84%$19.95 (−13.67%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 3h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 21, 2026